Moderna senior executive to speak at the ISPE conference

Published: 12-May-2022
Regulatory

As Chief Technical Operations and Quality Officer, Andres is responsible for the supply of products required for the company’s preclinical and clinical development programmes

The International Society for Pharmaceutical Engineering (ISPE) announced Juan Andres, Chief Technical Operations and Quality Officer of Moderna, will be the closing keynote speaker for the 2022 ISPE Biotechnology Conference, taking place 28-30 June 2022 in Boston, Massachusetts and virtually.

During Andres’s closing keynote address, he will discuss “Ideas to Performance: The Impossible Journey,” and explore Moderna’s journey from start-up to scale-up, overcoming challenges, and moving into the future. Andres will give an overview of the company’s pre-pandemic background, COVID preparation and operations insights, executing against the plan, and the company’s future operations.

As Chief Technical Operations and Quality Officer, Andres is responsible for the supply of products required for the company’s preclinical and clinical development programmes and scaling the CMC (chemistry, manufacturing, and controls) processes across its portfolio. He also leads all CMC late-stage development and future commercialisation activities.

The conference aims to highlight what’s in store for the future of biopharmaceutical manufacturing, examining how companies are developing modalities and adapting to the current manufacturing environment through the modernisation of ageing facilities and the adoption of approaches and processes.

Pictured: Juan Andres, Chief Technical Operations and Quality Officer, Moderna
  • Companies:
  • ISPE International Society for Pharmaceutical Engineering
  • Moderna Therapeutics
See more

You may also like

Regulatory

Moderna's updated COVID-19 vaccine gets the green light from the FDA

Read more
This year's version of the KP.2-targeting vaccine will endeavour to curb local COVID-19 outbreaks

Trending Articles

  1. Accelerating and enhancing toxicology assessments Infographic guides users through ToxHQ’s speedy assessment features
  2. You need to be a subscriber to read this article.
    Click here to find out more.
    Merck jumps on the GLP-1 therapeutic bandwagon by licensing Hansoh Pharma's HS-10535 Merck will be responsible for the development, manufacture and commercialisation of the investigational preclinical oral GLP-1 receptor agonist
  3. Bayer's acoramidis recommended for approval by the EMA's CHMP for cardiomyopathy The orally administered transthyretin (TTR) stabiliser is suitable for patients with transthyretin amyloid cardiomyopathy, demonstrating at least a 90% TTR stabilisation capacity and a reduction in cardiovascular-related hospitalisations
  4. You need to be a subscriber to read this article.
    Click here to find out more.
    Why quality control should be intimately combined with sterile product development, manufacturing and the overall product supply chain With sponsor companies increasingly needing to create and launch differentiated, stable, usable and safe injectable treatments for patients, experts at ten23 health are keen to promote the importance of integrating development and/or manufacturing with quality control services
  5. The right validation model: practical considerations and applications It is widely accepted that validation in the life sciences industry follows a lifecycle model (1,2). What is not always clear is the specific model — or models — to follow and how to navigate through them in the real world. Hurdles to overcome include the specific deliverables that make up that model and how they change during the various interactions along the validation journey

Upcoming event

EMPQ Essentials and Real-World Strategies for Successful Cleanroom Qualifications

16 January 2025 | Virtual See all

You may also like

Regulatory

Moderna's updated COVID-19 vaccine gets the green light from the FDA

This year's version of the KP.2-targeting vaccine will endeavour to curb local COVID-19 outbreaks
Distribution

Moderna receives positive opinion from the EMA for Spikevax

Moderna has revealed the European Medicine's Agency (EMA) has provided positive opinion on its COVID-19 vaccine Spikevax's marketing authorisation
Regulatory

ISPE provides new guidance on membrane-based water-for-injection systems

The International Society for Pharmaceutical Engineering (ISPE) announces the release of the ISPE Good Practice Guide: Membrane-Based Water-for-Injection Systems
Regulatory

ISPE releases guide to change management systems

Built upon the ICH Q10 Pharmaceutical Quality System (PQS) model, the programme is an industry-led approach
Regulatory

ISPE releases ATMPs facilities guide

The term ATMP is broad and refers to emerging therapies that utilise rapidly evolving technology and equipment
Regulatory

ISPE releases second edition guide to good engineering practice

Updates for the second edition include alignment with current industry practice
Regulatory

ISPE releases guide to 'Enabling Innovation'

Improving patient safety, product quality and providing value to society while reducing costs requires constant and effective innovation
Subscribe now